Type 1 diabetes should not be a barrier to treating the disease of obesity effectively with obesity medications, Al Ozairi and le Roux said
Creatives helped boost user engagement and supported ad teams in expanding reach efficiently
This can help reduce overall calorie intake, leading to weight loss
Preclinical studies have explored its potential effects on the gastrointestinal tract, muscles, ligaments, tendons, and nerves
Consistently, the STEP (Semaglutide Treatment Effect in People with Obesity) trial [22] demonstrated that after 68 weeks of semaglutide therapy in individuals who are overweight or obese, the average weight loss achieved was 14.9%, with 86.4% of participants achieving a reduction of at least 5% from baseline, and 69.1% and 50.5% achieving reductions exceeding 10% and 15%, respectively